Literature DB >> 8356076

A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population.

E E Manuelidis1, L Manuelidis.   

Abstract

The etiology of most human dementias is unknown. Creutzfeldt-Jakob disease (CJD), a relatively uncommon human dementia, is caused by a transmissible virus-like agent. Molecular markers that are specific for the agent have not yet been defined. However, the infectious disease can be transmitted to rodents from both brain and infected buffy coat (blood) samples. To determine whether human CJD infections are more widespread than is apparent from the low incidence of neurological disease, we attempted to transmit CJD from buffy coat samples of 30 healthy volunteers who had no family history of dementing illness. Primary transmissions from 26 of 30 individuals produced CJD-like spongiform changes in the brains of recipient hamsters at 200-500 days postinoculation. This positive evidence of viremia was found for individuals in all age groups (20-30, 40-50, and 61-71 years old), whereas 12 negatively scored brain samples failed to produce similar changes in hamsters observed for > 900 days in the same setting. We suggest that a CJD agent endemically infects humans but only infrequently produces an infectious dementia. Disease expression is likely to be influenced by several host factors in combination with viral variants that have altered neurovirulence.

Entities:  

Mesh:

Year:  1993        PMID: 8356076      PMCID: PMC47215          DOI: 10.1073/pnas.90.16.7724

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Potential retroviral RNAs in Creutzfeldt-Jakob disease.

Authors:  G H Murdoch; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

Review 2.  Potential involvement of retroviral elements in human dementias.

Authors:  L Manuelidis; G Murdoch; E E Manuelidis
Journal:  Ciba Found Symp       Date:  1988

3.  Physical properties of the Creutzfeldt-Jakob disease agent.

Authors:  T K Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  Astrocyte gene expression in Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; D M Tesin; T Sklaviadis; E E Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Cerebrovascular amyloid in scrapie-affected sheep reacts with antibodies to prion protein.

Authors:  D Allsop; S Ikeda; M Bruce; G G Glenner
Journal:  Neurosci Lett       Date:  1988-10-05       Impact factor: 3.046

6.  Growth factor production by Creutzfeldt-Jakob disease cell lines.

Authors:  E L Oleszak; G Murdoch; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice.

Authors:  R H Kimberlin; C A Walker; H Fraser
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

Review 8.  Suggested links between different types of dementias: Creutzfeldt-Jakob disease, Alzheimer disease, and retroviral CNS infections.

Authors:  E E Manuelidis; L Manuelidis
Journal:  Alzheimer Dis Assoc Disord       Date:  1989 Spring-Summer       Impact factor: 2.703

9.  Identification of two determinants that attenuate vaccine-related type 2 poliovirus.

Authors:  R B Ren; E G Moss; V R Racaniello
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.

Authors:  A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more
  8 in total

1.  Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease.

Authors:  Laura Manuelidis; Zhi Yun Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

2.  Failure to transmit disease from gray tremor mutant mice.

Authors:  G A Carlson; S Banks; D Lund; C Reichert; D Groth; M Torchia; S J Dearmond; S B Prusiner
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 3.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

4.  Prion diseases and the 'protein only' hypothesis: a theoretical dynamic study.

Authors:  M Laurent
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

Review 5.  Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: implications for physicians.

Authors:  C MacKnight; K Rockwood
Journal:  CMAJ       Date:  1996-09-01       Impact factor: 8.262

6.  Prion diseases: dynamics of the infection and properties of the bistable transition.

Authors:  N Kellershohn; M Laurent
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

Review 7.  Cross currents in protein misfolding disorders: interactions and therapy.

Authors:  Rodrigo Morales; Kristi M Green; Claudio Soto
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

Review 8.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.